vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and FIRSTSUN CAPITAL BANCORP (FSUN). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $110.0M, roughly 1.9× FIRSTSUN CAPITAL BANCORP). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs 8.3%, a 11.4% gap on every dollar of revenue. Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 6.9%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
COLL vs FSUN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $110.0M |
| Net Profit | $17.0M | $21.6M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | 19.6% |
| Revenue YoY | 12.9% | — |
| Net Profit YoY | 35.3% | -8.4% |
| EPS (diluted) | $0.48 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $110.0M | ||
| Q4 25 | $205.4M | $110.2M | ||
| Q3 25 | $209.4M | $107.3M | ||
| Q2 25 | $188.0M | $105.6M | ||
| Q1 25 | $177.8M | $96.2M | ||
| Q4 24 | $181.9M | $98.7M | ||
| Q3 24 | $159.3M | $98.2M | ||
| Q2 24 | $145.3M | $96.2M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | $17.0M | $24.8M | ||
| Q3 25 | $31.5M | $23.2M | ||
| Q2 25 | $12.0M | $26.4M | ||
| Q1 25 | $2.4M | $23.6M | ||
| Q4 24 | $12.5M | $16.4M | ||
| Q3 24 | $9.3M | $22.4M | ||
| Q2 24 | $19.6M | $24.6M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | 29.0% | ||
| Q3 25 | 29.7% | 26.4% | ||
| Q2 25 | 18.7% | 31.2% | ||
| Q1 25 | 12.2% | 30.9% | ||
| Q4 24 | 20.9% | 20.4% | ||
| Q3 24 | 21.9% | 29.1% | ||
| Q2 24 | 32.7% | 32.3% |
| Q1 26 | — | 19.6% | ||
| Q4 25 | 8.3% | 22.5% | ||
| Q3 25 | 15.0% | 21.6% | ||
| Q2 25 | 6.4% | 25.0% | ||
| Q1 25 | 1.4% | 24.5% | ||
| Q4 24 | 6.9% | 16.6% | ||
| Q3 24 | 5.9% | 22.8% | ||
| Q2 24 | 13.5% | 25.5% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | $0.48 | $0.89 | ||
| Q3 25 | $0.84 | $0.82 | ||
| Q2 25 | $0.34 | $0.93 | ||
| Q1 25 | $0.07 | $0.83 | ||
| Q4 24 | $0.36 | $0.57 | ||
| Q3 24 | $0.27 | $0.79 | ||
| Q2 24 | $0.52 | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $413.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.2B |
| Total Assets | $1.7B | $8.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $413.7M | ||
| Q4 25 | $386.7M | $652.6M | ||
| Q3 25 | $285.9M | $659.9M | ||
| Q2 25 | $222.2M | $785.1M | ||
| Q1 25 | $197.8M | $621.4M | ||
| Q4 24 | $162.8M | $615.9M | ||
| Q3 24 | $120.0M | $573.7M | ||
| Q2 24 | $271.6M | $535.8M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $301.7M | $1.2B | ||
| Q3 25 | $274.8M | $1.1B | ||
| Q2 25 | $232.2M | $1.1B | ||
| Q1 25 | $234.4M | $1.1B | ||
| Q4 24 | $228.8M | $1.0B | ||
| Q3 24 | $234.3M | $1.0B | ||
| Q2 24 | $216.6M | $996.6M |
| Q1 26 | — | $8.6B | ||
| Q4 25 | $1.7B | $8.5B | ||
| Q3 25 | $1.6B | $8.5B | ||
| Q2 25 | $1.6B | $8.4B | ||
| Q1 25 | $1.6B | $8.2B | ||
| Q4 24 | $1.7B | $8.1B | ||
| Q3 24 | $1.6B | $8.1B | ||
| Q2 24 | $1.1B | $8.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $111.5M | ||
| Q3 25 | $78.4M | $49.4M | ||
| Q2 25 | $72.4M | $15.0M | ||
| Q1 25 | $55.4M | $26.4M | ||
| Q4 24 | $84.6M | $101.1M | ||
| Q3 24 | $-9.0M | $48.1M | ||
| Q2 24 | $67.4M | $20.9M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $104.0M | ||
| Q3 25 | $78.3M | $47.6M | ||
| Q2 25 | $72.4M | $13.0M | ||
| Q1 25 | $54.6M | $24.3M | ||
| Q4 24 | $84.1M | $95.7M | ||
| Q3 24 | $-9.2M | $47.1M | ||
| Q2 24 | $67.1M | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 94.3% | ||
| Q3 25 | 37.4% | 44.4% | ||
| Q2 25 | 38.5% | 12.3% | ||
| Q1 25 | 30.7% | 25.3% | ||
| Q4 24 | 46.2% | 97.0% | ||
| Q3 24 | -5.8% | 47.9% | ||
| Q2 24 | 46.2% | 20.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 6.8% | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | 0.0% | 1.9% | ||
| Q1 25 | 0.4% | 2.1% | ||
| Q4 24 | 0.3% | 5.5% | ||
| Q3 24 | 0.2% | 1.1% | ||
| Q2 24 | 0.2% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 4.49× | ||
| Q3 25 | 2.49× | 2.13× | ||
| Q2 25 | 6.05× | 0.57× | ||
| Q1 25 | 22.92× | 1.12× | ||
| Q4 24 | 6.75× | 6.18× | ||
| Q3 24 | -0.96× | 2.15× | ||
| Q2 24 | 3.44× | 0.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
